RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 74 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $42,000 | +7.7% | 96,985 | +110.2% | 0.00% | – |
| Q2 2022 | $39,000 | -96.0% | 46,130 | -73.6% | 0.00% | – |
| Q1 2022 | $964,000 | -67.0% | 174,812 | -42.1% | 0.00% | – |
| Q4 2021 | $2,920,000 | +169.4% | 301,758 | +397.7% | 0.00% | – |
| Q3 2021 | $1,084,000 | -85.2% | 60,629 | -79.7% | 0.00% | -100.0% |
| Q2 2021 | $7,306,000 | -29.0% | 299,286 | -23.0% | 0.00% | -50.0% |
| Q1 2021 | $10,295,000 | +819.2% | 388,500 | +163.4% | 0.00% | – |
| Q4 2020 | $1,120,000 | +1233.3% | 147,498 | +944.0% | 0.00% | – |
| Q2 2020 | $84,000 | +1.2% | 14,128 | -23.9% | 0.00% | – |
| Q1 2020 | $83,000 | -90.7% | 18,576 | -83.6% | 0.00% | – |
| Q3 2019 | $889,000 | +91.6% | 113,156 | +283.6% | 0.00% | – |
| Q2 2019 | $464,000 | – | 29,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |